Fresenius Medical Care AG

FME: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
h%BLOCK|@jb#LOCK|KR@Ynp<

Fresenius Medical Care Earnings: Solid Trends Put It on Target to Meet 2025 Expectations

In constant currency in the second quarter, Fresenius Medical Care generated 7% organic revenue growth, adjusted operating income growth of 13%, and adjusted EPS growth of 30% including lower interest, tax, and minority interest expenses. Management also confirmed their guidance for 2025.

Sponsor Center